List of Chrono Therapeutics patents

List of Chrono Therapeutics patents

List of Optical Air Data Systems, LLC patents

List of Croda International patents

List of Biomed Valley Discoveries patents

List of funding rounds for SimpleReach

List of food safety patents

Patents where

Current Assignee

Name

is

Chrono Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10258778 Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like	Patent 10258778 was granted and assigned to Chrono Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	10258778	April 16, 2019
	‌ US Patent 10258738 Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like	Patent 10258738 was granted and assigned to Chrono Therapeutics on April, 2019 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	10258738	April 16, 2019
	‌ US Patent 10232156 Drug delivery methods and systems	Patent 10232156 was granted and assigned to Chrono Therapeutics on March, 2019 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	10232156	March 19, 2019
	‌ US Patent 9669199 Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like	Patent 9669199 was granted and assigned to Chrono Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	9669199	June 6, 2017
	‌ US Patent 10213586 Drug delivery methods and systems	Patent 10213586 was granted and assigned to Chrono Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	10213586	February 26, 2019
	‌ US Patent 10105487 Optimized bio-synchronous bioactive agent delivery system	Patent 10105487 was granted and assigned to Chrono Therapeutics on October, 2018 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	10105487	October 23, 2018
	‌ US Patent RE46217 Portable drug delivery device including a detachable and replaceable administration or dosing element	Patent RE46217 was granted and assigned to Chrono Therapeutics on November, 2016 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	RE46217	November 29, 2016
	‌ US Patent 9555226 Transdermal drug delivery method and system	Patent 9555226 was granted and assigned to Chrono Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	9555226	January 31, 2017
	‌ US Patent 9555227 Biosynchronous transdermal drug delivery	Patent 9555227 was granted and assigned to Chrono Therapeutics on January, 2017 by the United States Patent and Trademark Office.	Chrono Therapeutics	Chrono Therapeutics		United States Patent and Trademark Office	9555227	January 31, 2017

9 results

0 selected

9 results

0 selected